Show simple item record

dc.contributor.editorTuoti, Whitney Alexandraen_US
dc.creatorMeek, Carolineen_US
dc.date.accessioned2021-03-01T18:51:24Zen_US
dc.date.available2021-03-01T18:51:24Zen_US
dc.date.created2021-03-01en_US
dc.identifier.urihttps://hpsrepository.asu.edu/handle/10776/13232en_US
dc.description.abstractThe problem of whether women should be involved in drug research is a question of who can assume risk and who is responsible for disseminating what specific kinds of information. The problem tends to be framed as one that juxtaposes the health of women and fetuses and sets their health as in opposition. That opposition, coupled with the inherent uncertainty in testing drugs, provides for a complex set of issues surrounding consent and access to information.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoen_USen_US
dc.language.isoen_USen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rightsCopyright Arizona Board of Regentsen_US
dc.subject.lcshResearch--Moral and ethical aspectsen_US
dc.subject.lcshResearchen_US
dc.subject.lcshMoral and ethical aspectsen_US
dc.subject.meshEthics, Researchen_US
dc.subject.meshResearch Ethicsen_US
dc.titleThesis: A History and Analysis of Drug Labeling Policy for Pregnant and Lactating Women and Women's Involvement in Clinical Drug Research from 1970 to 2014en_US
dc.typeThesisen_US
dc.typeThesisen_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.subject.embryoEthicsen_US
dc.subject.tagDrug research involving pregnant womenen_US
dc.subject.tagEthics of drug researchen_US
dc.description.typeEssays and Thesesen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record